Laboratorios Liomont
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Etoricoxib+Diacerein in Osteoarthritis. (NCT07549386) | Laboratorios Liomont | 2024-05-24 |
| Safety of Effivia®, a Bevacizumab Biosimilar (NCT06313268) | Laboratorios Liomont | 2022-08-11 |
| Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain (NCT05995912) | Laboratorios Liomont | 2021-09-29 |
| Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17. (NCT03460743) | Laboratorios Liomont | 2018-03-22 |
Track Laboratorios Liomont automatically
Every clearance here is in the API, with alerts when new ones post.